Kruthika Thangavelu
Overview
Explore the profile of Kruthika Thangavelu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rudhart S, Langen P, Thangavelu K, Gehrt F, Stankovic P, Wilhelm T, et al.
Anticancer Res
. 2021 Dec;
42(1):137-146.
PMID: 34969719
Background: Primary radio(chemo)therapy [R(C)T] is a treatment option for advanced oropharyngeal squamous cell carcinoma (OSCC). Nevertheless, early diagnostics of treatment failure is problematic. Cytokeratin fragment 19 (CYFRA 21-1), an established...
12.
Thangavelu K, Kohnlein S, Eivazi B, Gurschi M, Stuck B, Geisthoff U
HNO
. 2021 Oct;
69(11):931-942.
PMID: 34643746
Nosebleeds (epistaxis) are usually minor. Medical intervention is only necessary in about 6% of cases. The source of bleeding is frequently located in the anterior region of the nose (Kiesselbach's...
13.
Droege F, Stang A, Thangavelu K, Lueb C, Lang S, Xydakis M, et al.
J Clin Med
. 2021 Jun;
10(9).
PMID: 34066446
Background: Recurrent bleeding in patients with hereditary hemorrhagic telangiectasia (HHT) can lead to chronic iron deficiency anemia (CIDA). Existing research points to CIDA as a contributing factor in restless leg...
14.
Droege F, Kuerten C, Kaiser C, Dingemann J, Kaster F, Dahlfrancis P, et al.
Laryngorhinootologie
. 2021 Mar;
100(6):443-452.
PMID: 33761571
Objective: Patients with hereditary hemorrhagic Telangiectasia (HHT) suffer from a rare and systemic disease which is characterized by vascular malformations leading to a variety of different symptoms. Material And Methods:...
15.
Droege F, Dingemann J, Thangavelu K, Kuerten C, Dahlfrancis P, Kaiser C, et al.
Laryngorhinootologie
. 2021 Mar;
100(5):372-381.
PMID: 33723832
Objective: Hereditary Hemorrhagic Telangiectasia (HHT) is a rare and systemic disorder which is characterized by recurrent epistaxis, mucocutaneous telangiectases, and visceral arteriovenous malformations (AVM). An interdisciplinary concept is recommended. Material...
16.
Rudhart S, Gunther F, Dapper L, Thangavelu K, Geisthoff U, Stankovic P, et al.
Eur Arch Otorhinolaryngol
. 2021 Mar;
278(10):4075-4080.
PMID: 33713189
Background: Reprocessing of flexible endoscopes (FEs) is often expensive, time consuming, and becomes increasingly complex, due to rising demands of hygiene. After beneficial results in reprocessing of rigid endoscopes using...
17.
Geisthoff U, Nguyen H, Lefering R, Maune S, Thangavelu K, Droege F
J Clin Med
. 2020 May;
9(5).
PMID: 32429545
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease of the fibrovascular tissue resulting in visceral vascular malformations and (muco-) cutaneous telangiectases with recurrent bleedings. The mechanism behind the disease...
18.
Rudhart S, Gunther F, Dapper L, Thangavelu K, Gehrt F, Stankovic P, et al.
Eur Arch Otorhinolaryngol
. 2020 May;
277(8):2363-2369.
PMID: 32358650
Background: Reprocessing of endoscopes becomes increasingly complex, due to rising demands of hygiene. Established methods are often expensive/time-consuming. Recent studies suggest beneficial aspects of disinfection by UV light. In this...
19.
Droege F, Pylaeva E, Siakaeva E, Bordbari S, Spyra I, Thangavelu K, et al.
J Clin Med
. 2020 Mar;
9(3).
PMID: 32178330
Hereditary hemorrhagic telangiectasia (HHT) is characterized by mucocutaneous telangiectases and visceral vascular malformations. Individuals suffering from HHT have a significantly increased risk of bacterial infections, but the mechanisms involved in...
20.
Thangavelu K, Martakis K, Fabian S, Venkateswaran M, Roth B, Beutner D, et al.
Acta Paediatr
. 2019 May;
108(11):1972-1977.
PMID: 31074050
Aim: Hearing loss in infants is often diagnosed late, despite universal screening programmes. Risk factors of hearing impairment in high-risk neonates, identified from population-based studies, can inform policy around targeted...